BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Analyst Maintains Sell Rating on HIMS Stock Amid Women’s Health Expansion Buzz
Analyst Maintains Sell Rating on HIMS Stock Amid Women’s Health Expansion Buzz
13
3
BTCCSquare news:
Hims & Hers Health (HIMS) faces a divergence between analyst skepticism and investor Optimism as it expands into women’s health. Bank of America Securities’ four-star analyst Allen Lutz reiterated a Sell rating despite the stock’s 16.18% surge following the launch of menopause and perimenopause treatment plans. The women’s health division, already serving 500,000 subscribers, is projected to top $1 billion in annual revenue by 2026.
Pre-market trading saw a 1.4% pullback, underscoring the market’s volatility. The disconnect highlights broader tensions between growth narratives and fundamental valuations—a dynamic familiar to crypto markets where speculative fervor often outpaces traditional analysis.
By:
